| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6001876 | Thrombosis Research | 2015 | 8 Pages |
Abstract
Despite of the use of aspirin, most platelet activation properties were in the normal range in whole-blood from class II PAD patients. These data underline the need for more effective antithrombotic pharmacoprotection in PAD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Johanna P. van Geffen, Marie-Claire Kleinegris, Remco Verdoold, Constance C.F.M.J. Baaten, Judith M.E.M. Cosemans, Kenneth J. Clemetson, Hugo ten Cate, Mark Roest, Bas de Laat, Johan W.M. Heemskerk,